Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Irreversible visual loss in dermatomyositis

L M Yeo1, D S Swaby, R D Situnayake

  • 1Birmingham And Midland Eye Hospital And City Hospital NHS Trust, Birmingham, USA.

British Journal of Rheumatology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does access to a portable ophthalmoscope improve skill acquisition in direct ophthalmoscopy? A method comparison study in undergraduate medical education.

BMC medical education·2019
Same author

Can general A&E doctors manage common eye emergencies?

Eye (London, England)·2016
Same author

Immunohistochemical and cytokine analysis of eyes from rats with adjuvant arthritis.

Ocular immunology and inflammation·2012
Same author

The detection of herpesviral DNA in aqueous fluid samples from patients with Fuchs' heterochromic cyclitis.

Ocular immunology and inflammation·2012
Same author

Von Willebrand factor, endothelial damage and ocular disease.

Ocular immunology and inflammation·2012
Same author

Coats' disease and Fuchs' heterochromic cyclitis.

Ocular immunology and inflammation·2012
Same journal

Sensorineural hearing loss, iritis and ankylosing spondylitis.

British journal of rheumatology·1999
Same journal

Outcome in systemic vasculitis.

British journal of rheumatology·1999
Same journal

Infection with an unenveloped DNA virus (TTV) associated with non-A to G hepatitis in patients with rheumatoid arthritis.

British journal of rheumatology·1999
Same journal

Aortitis in relapsing polychondritis.

British journal of rheumatology·1999
Same journal

Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis.

British journal of rheumatology·1999
Same journal

Haemophagocytic syndrome in a patient with dermatomyositis.

British journal of rheumatology·1999
See all related articles

Dermatomyositis can cause rare but severe vision loss due to retinal complications. Prompt immunosuppressive therapy is crucial for managing intraocular inflammation, though damage may be irreversible.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Systemic Autoimmune Diseases

Background:

  • Dermatomyositis is an inflammatory myopathy associated with various systemic manifestations.
  • Ocular involvement in dermatomyositis, including retinopathy, is documented but typically does not lead to significant visual impairment.

Observation:

  • This report details an unusual case of dermatomyositis presenting with severe retinal complications.
  • The patient experienced permanent and profound central visual loss attributed to these ocular issues.

Findings:

  • Treatment with pulsed intravenous and oral methylprednisolone and cyclophosphamide effectively controlled the systemic dermatomyositis.
  • Despite aggressive immunosuppressive therapy, the macular and optic disc damage remained irreversible, resulting in permanent vision loss.

Related Experiment Videos

Implications:

  • Early diagnosis and aggressive immunosuppressive treatment are vital for controlling potentially blinding intraocular inflammation in dermatomyositis.
  • Close collaboration between ophthalmologists and physicians is essential for optimal management of ocular complications in dermatomyositis.